APA (7th ed.) Citation

AV, S., SE, M., D, Z., L, V., M, S., JC, P., . . . SW, F. (2007). Survivin depletion preferentially reduces the survival of activated K-Ras-transformed cells. Molecular cancer therapeutics, 6(1), 269. https://doi.org/10.1158/1535-7163.MCT-06-0560

Chicago Style (17th ed.) Citation

AV, Sarthy, et al. "Survivin Depletion Preferentially Reduces the Survival of Activated K-Ras-transformed Cells." Molecular Cancer Therapeutics 6, no. 1 (2007): 269. https://doi.org/10.1158/1535-7163.MCT-06-0560.

MLA (9th ed.) Citation

AV, Sarthy, et al. "Survivin Depletion Preferentially Reduces the Survival of Activated K-Ras-transformed Cells." Molecular Cancer Therapeutics, vol. 6, no. 1, 2007, p. 269, https://doi.org/10.1158/1535-7163.MCT-06-0560.